Trial intelligence / Profile preview

Dexmedetomidine Versus Ketamine to Facilitate Non-invasive Ventilation After Blunt Chest Trauma

NCT05175781Completed

Sponsor
Aswan University Hospital
Start
Jan 2022
Primary completion
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in chest trauma comparing Dexmedetomidine, Ketamine and Placebo (3 arms). Primary endpoint: Duration of non-invasive ventilation session at 8 hours. Started Jan 2022; status: completed.

02

Drugs

dexmedetomidineketamine
03

Conditions

chest trauma

Beyond the preview

Go deeper on NCT05175781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05175781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call